hsa-miR-92b-3phsa-miR-938hsa-miR-4683hsa-miR-3157-3phsa-miR-620hsa-miR-6880-5phsa-miR-92a-3phsa-miR-7703hsa-miR-665hsa-miR-4537hsa-miR-5195-3phsa-miR-3180-5phsa-miR-6516-5phsa-miR-6886-3phsa-miR-1270hsa-miR-10b-3phsa-miR-4325hsa-miR-5186hsa-miR-367-3phsa-miR-4459hsa-miR-874-3phsa-miR-145-5phsa-miR-6499-3phsa-miR-3912-5phsa-miR-6780b-3phsa-miR-25-3phsa-miR-6851-5phsa-miR-32-5phsa-miR-455-3phsa-miR-3689dhsa-miR-6134hsa-miR-363-3phsa-miR-767-5p
P128
P684
Phenotyping and genotyping of CYP2C19 using comparative metabolism of proguanil in sickle-cell disease patients and healthy controls in Nigeria.Hypothermia in an Adolescent Due to Probable Drug-Drug Interaction Involving ClobazamAssociation of CYP2C19 Polymorphisms With Clopidogrel Reactivity and Clinical Outcomes in Chronic Ischemic StrokeCytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic ImplicationsInfluence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
P921
Q27592842-8E3800FE-B0E3-459F-935B-A76E3C0E753AQ27592961-6AAF1A16-6F00-4C9F-8359-4CF1DC2EE452Q27592965-5D6A6247-FF30-444E-BEA9-65C237BBB1FAQ27592989-C08181D7-8B04-42FF-B98B-8D983E4F22D3Q27593272-5483AFAC-87DD-4E27-A563-9B5FBDF23F91Q27593285-31145393-2042-4C30-8ABF-1F8ECE2C50E0Q27593334-C7FB169A-9A1C-4B22-BE7D-3579878A22D8Q27593357-4F3881A4-4F1B-4150-80B3-E6A075864703Q27593405-28B47395-A182-4C57-BF44-2D0499B82651Q27593510-B801DD24-11CB-4E3C-A1A5-526D911620B1Q27593512-7F5486BA-B8B5-4B52-BE83-17227B30BB3DQ27593630-720F9CB2-580A-41FE-9085-994E46761401Q27593842-4982B5DA-A198-400F-8147-DF6D4DA32CA1Q27593953-9DB636A3-B6FE-4970-B895-5014AADE3B92Q27593984-B31AA7CB-F614-4E4A-88E1-F2548C387B89Q27594218-DE27BC77-086D-4BE0-9FB6-BB7DC85E47F1Q27594323-3E2EC453-DB77-4D18-9153-BE4D95FD307FQ27594546-5C5F8A1E-65AB-45D1-BF0B-1D139DA01AB6Q27594623-E755AB50-C2FA-46C3-8435-773CA26997E1Q27594677-7C7EA339-BD89-43FC-BDC3-4421B35C3F0DQ27594710-C9FAF837-5CA5-4F51-B776-155589AE1D3DQ27594721-84871F0B-85DA-49D8-956B-04AC326C6435Q27594726-9A13F028-402B-40C5-98FF-B37D689C53AAQ27594739-6E751A8F-1F36-4D61-A683-AD6CE9D5BE20Q27594807-EDD742F7-C198-4251-950B-3EAE09DD56F7Q27594904-B88777ED-9F0D-4FA1-8784-F786B3CF651FQ27595082-49343CA1-A84C-47DE-814A-DB0C6A443280Q27595127-437AE0EE-D2DC-457A-B160-928229858FBFQ27595135-73D58721-1CF8-4CEF-AF27-3066C320F409Q27595164-BFABD527-8FF7-417F-A611-C69CE8DD64C1Q27595194-4858E3BD-0A8E-43BF-BAFB-657310952916Q27595278-D3DE200C-E0CB-4339-90A6-11E98CCBF717Q27595344-A9AAB8EB-D66C-404E-93A4-7BDF664796FB
P128
Q28922670-EBDB3035-AF40-4F23-9A86-32A19B1423AFQ30151266-BB8CEA7F-A0AF-4559-96F8-99760FD5E8CCQ30225558-6D6D773C-9A80-4CA5-8D50-AA133D27A7E8Q30230991-8B0C257F-AAA8-453C-9BAC-488AF636A756Q30231000-59CE9D33-1E5E-4427-8079-DA0CBDF7FF67Q44014809-D0203CF8-4C50-4D02-921B-EA397ECDE9D8Q44017540-D54C0B16-9169-4B47-B496-E4C543FE1009Q54989029-4B52799E-BBF7-45DF-A132-2C626D2F96B0
P527
description
Gen der Spezies Homo sapiens
@de
Genen från arten Homo sapiens
@sv
gen de la especie Homo sapiens
@es
gen fu a sortu Homo sapiens
@srn
gen van de soort Homo sapiens
@nl
gene da espécie Homo sapiens
@pt
gene umano
@it
genyn codio-protien yn y rhywogaeth Homo sapiens
@cy
gjen i llojit Homo sapiens
@sq
gène de l'espèce Homo sapiens
@fr
name
CYP2C19
@cy
CYP2C19
@de
CYP2C19
@en
CYP2C19
@es
CYP2C19
@fr
CYP2C19
@it
CYP2C19
@ja
CYP2C19
@nl
CYP2C19
@pt
CYP2C19
@srn
type
label
CYP2C19
@cy
CYP2C19
@de
CYP2C19
@en
CYP2C19
@es
CYP2C19
@fr
CYP2C19
@it
CYP2C19
@ja
CYP2C19
@nl
CYP2C19
@pt
CYP2C19
@srn
altLabel
CPCJ
@en
CYP2C
@en
CYPIIC17
@en
CYPIIC19
@en
P450C2C
@en
P450IIC19
@en
cytochrome P450 family 2 subfamily C member 19
@en
prefLabel
CYP2C19
@cy
CYP2C19
@de
CYP2C19
@en
CYP2C19
@es
CYP2C19
@fr
CYP2C19
@it
CYP2C19
@ja
CYP2C19
@nl
CYP2C19
@pt
CYP2C19
@srn
P704
P351
P594
P6366
P1057
P2548
P2888
P31
P353
P4196
P492
P593
P594
ENSG00000165841